Tweets
ANCA-associated vasculitis: beyond therapy with rituximab?
AAV is a group of multi-system autoimmune small vessel vasculitides which includes GPA, MPA and EGPA.
https://t.co/eZ3mgdjrEp https://t.co/dM9B4tVgmr
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Methotrexate - an old trusted friend who deserves better
MTX has been used as the anchor drug for the treatment of RA and PsA for many years. It has been co-prescribed with biologics and JAKi in clinical trials and as well as in clinical practice.
https://t.co/xp40KklMkA https://t.co/oVqzlQeqbe
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
RheumNow Eular2023 Coverage - SLE Panel Discussion https://t.co/pLWOqZo2aw https://t.co/itAOjgmMTl
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
AOSD: Young vs. Elderly Onset
AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million.
https://t.co/fg5TakEvvv https://t.co/lu34gX7WTZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
EULAR 2023 Notes from Milan
Dr. Jack Cush reviews highlight abstracts and sessions - covering lupus, RA, gout, Still's disease, safety data, AI in medicine and more - from last week's EULAR 2023 Congress held in Milan, Italy
https://t.co/brcgGv2GHD https://t.co/zVyZkEuLy4
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Assessing CV Risk in Inflammatory Arthritis: Which Score?
Dr. Aurelie Najm discusses OP0267 presented at EULAR 2023 in Milan, Italy.
https://t.co/MvqkKya4vm
@AurelieRheumo
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Combining a Tyk2 inhibitor with a JAKi in RA?
Dr. Janet Pope (@Janetbirdope ) weighs in on #EULAR23 abstracts.
https://t.co/7fTZjvnHT3 https://t.co/o43VrWpVpI
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
A step change towards self-empowerment for people living with SLE
As I reflect on my research journey, I recall several issues that still need to be addressed in the management of SLE.
https://t.co/ElunbUgSGF https://t.co/YmA1YWPxVP
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Postpartum Depression in RA
Dr. Jonathan Kay discusses abstract POS0206-HPR at EULAR 2023 in Milan, Italy.
https://t.co/dzUMIia8Q6 https://t.co/IjeEvz8Cab
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
The Importance of Identifying Central Pain in PsA
Dr. Eric Ruderman discusses abstracts OP0068 and OP0299 at EULAR 2023 in Milan, Italy.
https://t.co/5fjNTrQvNx https://t.co/E1ivkK2bFz
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Malignancy and CV Risk in Rheumatoid Arthritis
Dr. Jonathan Kay discusses OP0218, OP0219 and OP0211 at EULAR 2023 in Milan, Italy.
https://t.co/o5yrbCBaCb https://t.co/qptUCGb79q
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
JAKi in Rheumatoid Arthritis: Cancer and Cardiovascular Risks
Dr. Antoni Chan discusses abstracts OP0132, POS0831, and OP0133 presented at EULAR 2023 in Milan, Italy.
https://t.co/ApLaPf7uKP https://t.co/nbZgwIlHyb
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
